Total Payments
$13,478
2024 Payments
$1,201
Companies
46
Transactions
894
Medicare Patients
6,187
Medicare Billing
$845,400
Payment Breakdown by Category
Food & Beverage$13,381 (99.3%)
Education$97.08 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,381 | 879 | 99.3% |
| Education | $97.08 | 15 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,688 | 159 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,417 | 101 | $0 (2024) |
| Novo Nordisk Inc | $1,262 | 92 | $0 (2024) |
| Amgen Inc. | $1,078 | 66 | $0 (2024) |
| PFIZER INC. | $722.03 | 54 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $697.39 | 48 | $0 (2020) |
| Lilly USA, LLC | $685.13 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $554.93 | 44 | $0 (2022) |
| Merck Sharp & Dohme LLC | $529.32 | 42 | $0 (2023) |
| GlaxoSmithKline, LLC. | $458.09 | 35 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,201 | 61 | AstraZeneca Pharmaceuticals LP ($201.85) |
| 2023 | $629.90 | 30 | Amgen Inc. ($154.94) |
| 2022 | $668.13 | 39 | AstraZeneca Pharmaceuticals LP ($154.22) |
| 2021 | $549.40 | 27 | AstraZeneca Pharmaceuticals LP ($190.38) |
| 2020 | $1,129 | 71 | AstraZeneca Pharmaceuticals LP ($313.26) |
| 2019 | $2,786 | 200 | AstraZeneca Pharmaceuticals LP ($630.55) |
| 2018 | $3,178 | 218 | AstraZeneca Pharmaceuticals LP ($546.38) |
| 2017 | $3,336 | 248 | AstraZeneca Pharmaceuticals LP ($607.38) |
All Payment Transactions
894 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Diabetes Care | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Bone Health | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,491 | 2,792 | $483,915 | $222,307 |
| 2022 | 17 | 1,565 | 2,882 | $394,152 | $211,754 |
| 2021 | 15 | 1,457 | 2,847 | $395,315 | $219,475 |
| 2020 | 20 | 1,674 | 3,298 | $412,241 | $191,863 |
Total Patients
6,187
Total Services
11,819
Medicare Billing
$845,400
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 509 | 1,459 | $281,587 | $121,790 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 252 | 412 | $106,708 | $49,521 | 46.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 100 | 100 | $18,000 | $12,623 | 70.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 158 | $20,856 | $9,214 | 44.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $10,395 | $9,023 | 86.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $19,188 | $7,118 | 37.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 55 | 55 | $4,840 | $3,953 | 81.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 150 | 260 | $6,500 | $2,425 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 62 | 62 | $2,170 | $1,869 | 86.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,905 | $1,753 | 44.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,400 | $1,206 | 86.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 21 | 22 | $3,300 | $881.27 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 60 | 82 | $4,510 | $799.08 | 17.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 28 | 30 | $300.00 | $96.30 | 32.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 16 | $256.00 | $35.20 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 464 | 1,437 | $232,395 | $119,624 | 51.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 193 | 291 | $63,489 | $36,334 | 57.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 205 | $23,100 | $11,350 | 49.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 136 | 136 | $11,914 | $9,312 | 78.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 61 | 61 | $10,980 | $7,949 | 72.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 28 | 30 | $12,030 | $6,645 | 55.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $9,278 | $4,581 | 49.4% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 19 | 19 | $5,320 | $4,535 | 85.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 144 | 146 | $5,110 | $4,287 | 83.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 149 | 293 | $7,325 | $2,810 | 38.4% |
About Dr. Anthony Amabile, MD
Dr. Anthony Amabile, MD is a Internal Medicine healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669445078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Amabile, MD has received a total of $13,478 in payments from pharmaceutical and medical device companies, with $1,201 received in 2024. These payments were reported across 894 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($13,381).
As a Medicare-enrolled provider, Amabile has provided services to 6,187 Medicare beneficiaries, totaling 11,819 services with total Medicare billing of $845,400. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Virginia Beach, VA
- Active Since 02/08/2006
- Last Updated 04/09/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669445078
Products in Payments
- FARXIGA (Drug) $1,556
- JARDIANCE (Drug) $923.95
- Ozempic (Drug) $647.26
- XARELTO (Drug) $462.13
- Vascepa (Drug) $435.35
- Repatha (Biological) $418.23
- SYMBICORT (Drug) $386.04
- STIOLTO RESPIMAT (Drug) $363.96
- ENTRESTO (Drug) $335.49
- Trintellix (Drug) $267.40
- TOUJEO (Drug) $261.49
- ELIQUIS (Drug) $251.49
- BYDUREON (Drug) $237.26
- JANUVIA (Drug) $235.43
- CHANTIX (Drug) $206.22
- TRULICITY (Drug) $202.58
- Aimovig (Biological) $198.84
- ANORO (Drug) $192.60
- Victoza (Drug) $190.67
- Otezla (Drug) $187.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Virginia Beach
Dr. Garfield Samuels, M.d, M.D
Internal Medicine — Payments: $144,009
Internal Medicine $144,009
Herbert Knight, M.d, M.D
Internal Medicine — Payments: $11,019
Internal Medicine $11,019
Dr. David Haden, M.d, M.D
Internal Medicine — Payments: $9,475
Internal Medicine $9,475
Vera Goode, Md, MD
Internal Medicine — Payments: $8,369
Internal Medicine $8,369
Rajul Malik, Md, MD
Internal Medicine — Payments: $6,478
Internal Medicine $6,478
Susan Ring, Md, MD
Internal Medicine — Payments: $5,413
Internal Medicine $5,413